Scleroligation for Eradication of Gastroesophageal Varices.

Phase 3

• Conditions: Gastroesophageal Varices

• Registration Number: NCT02646202
• Lead Sponsor: Sherief Abd-Elsalam

Brief Summary

Gastric varices occur in 5-33% of patients with portal hypertension. Concomitant gastro esophageal varices are the most common type. Both endoscopic sclerotherapy and band ligation are very effective in controlling acute esophageal varices bleeding and preventing rebleeding.

Detailed Description

Evaluation of a new scleroligation technique for management of bleeding gastro-esophageal varices regarding efficacy, complications, variceal recurrence, and survival.

Study Timeline

• Study Start: 2015-01
• Study First Submitted: 2016-01-01
• Study First Submitted QC: 2016-01-01
• Study First Posted: 2016-01-05
• Status Verified: 2017-12
• Last Update Submitted: 2017-12-22
• Last Update Posted: 2017-12-27
• Primary Completion: 2021-12
• Study Completion: 2021-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• cirrhotic patients presenting with an acute or recent episode of gastro-esophageal variceal bleeding.

Exclusion Criteria

• Patients were excluded if they had malignancy of any origin.
• Any terminal illness, such as heart failure, uremia, or chronic pulmonary diseases.
• Other potential causes of GIT bleeding.
• Patients with previous endoscopic or surgical intervention for varices were also excluded.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Number of sessions to complete variceal obliteration	1 year

Trial Locations

Locations (1)

Tropical medicine dept.-Tanta university hospital; 🇪🇬 Tanta, Egypt